TAMIFLU
-
Opinions on drugs -
Posted on
Nov 02 2011
- Updated on
Dec 06 2011
Reason for request
Re-assessment of the actual benefit (AB) as a curative influenza treatment during periods of virus circulation and during an influenza pandemic in accordance with article R 163 12 of the Social Security Code. Extension of indication to children less than 1 year of age during an influenza pandemic outbreak as curative and prophylactic treatment of influenza.
-
Clinical Benefit
Low |
The actual benefit of TAMIFLU as a curative influenza treatment, when initiated within 48 hours of the onset of symptoms, during a period of ordinary influenza epidemic or a pandemic period is low in : The actual benefit as a curative treatment in pandemic periods is low in children less than 12 months of age.
|
Insufficient |
The actual benefit in influenza treatment is insufficient in other situations. The actual clinical benefit as a prophylactic treat ment in pandemic periods is insufficient in children less than 12 months of age. |
English version
Contact Us
Évaluation des médicaments